Memantine Hydrochloride
Who holds supplier records for Memantine Hydrochloride? 29 organisations hold a current record for Memantine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (18), Italy (4), China (2), Netherlands (1) and 3 other countries (3); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Memantine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/memantine-hydrochloride
Reading the evidence
- 29 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
18 of the 28 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 18 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (29)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Memantine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 23108 · latest filing Sept 2009
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 24778 · latest filing Mar 2011
- HIKAL LTDIndiaCEP Company GMP cert on recordActive DMF 23567 · latest filing Feb 2010
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20362 · latest filing Mar 2007
- MSN PHARMACHEM PRIVATE LTDIndiaCEPActive DMF 22112 · latest filing Oct 2008
- TAPI NL BVNetherlandsCEPActive DMF 20868 · latest filing Sept 2007
- Zhejiang Supor Pharmaceuticals Co., LtdChinaCEP Company GMP cert on recordActive DMF 38425 · latest filing May 2023
- AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPAItalyActive DMF 19549 · latest filing Jun 2006
- APISYN HEALTHCARE PRIVATE LIMITEDIndiaActive DMF 44142 · latest filing Jun 2026
- Apotex Inc.CanadaActive DMF 21199 · latest filing Dec 2007
- COHANCE LIFESCIENCES LTDIndia Company GMP cert on recordActive DMF 29180 · latest filing Mar 2015
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 20841 · latest filing Sept 2007
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 25321 · latest filing Oct 2011
- HAINAN POLY PHARMACEUTICAL CO LTDActive DMF 34870 · latest filing May 2020
- INDUSTRIALE CHIMICA SRLItaly Company GMP cert on recordActive DMF 19465 · latest filing May 2006
- Lupin LimitedIndia Company GMP cert on recordActive DMF 20456 · latest filing Mar 2007
- Macleods Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 24381 · latest filing Nov 2010
- MEGAFINE PHARMA P LTDIndiaActive DMF 25402 · latest filing Oct 2011
- OLON SPAItaly Company GMP cert on recordActive DMF 18562 · latest filing Jul 2005
- OLPHA ASLatvia Company GMP cert on recordActive DMF 20543 · latest filing May 2007
- ORBION PHARMACEUTICALS PRIVATE LTDIndia Company GMP cert on recordActive DMF 20848 · latest filing Sept 2007
- PROCOS SPAItaly Company GMP cert on recordActive DMF 26269 · latest filing Jul 2012
- SHARON BIO MEDICINE LTDIndia Company GMP cert on recordActive DMF 25194 · latest filing Aug 2011
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 20940 · latest filing Oct 2007
- Unichem Laboratories Ltd.India Company GMP cert on recordActive DMF 22886 · latest filing Jun 2009
- WANYANG HENGSHUI PHARMACEUTICAL CO LTDChinaActive DMF 40942 · latest filing Jan 2025
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 36574 · latest filing Dec 2021
- IndiaCEP
- KRKA TOVARNA ZDRAVIL D.D.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (9)
Certificates of Suitability on the EDQM register for Memantine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HIKAL LIMITED Bengaluru | IN | CEP 2026-275 - Rev 00 Memantine hydrochloride | Oct 2026 | Inspected Nov 2025 Switzerland |
| ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO., LTD. Shaoxing | CN | CEP 2025-311 - Rev 01 Memantine hydrochloride | Oct 2026 | Inspected Oct 2024 Belgium |
| TAPI NL B.V. Amsterdam | NL | CEP 2026-082 - Rev 00 Memantine hydrochloride | Jun 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2025-320 - Rev 00 Memantine hydrochloride | Jun 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2026-017 - Rev 00 Memantine hydrochloride | May 2026 | — |
| KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto | SI | CEP 2025-376 - Rev 00 Memantine hydrochloride | Apr 2026 | Inspected Jul 2025 Slovenia |
| MEGAFINE PHARMA PRIVATE LIMITED Mumbai | IN | CEP 2025-233 - Rev 00 Memantine hydrochloride | Mar 2026 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2025-110 - Rev 00 Memantine hydrochloride, Form-I | Feb 2026 | — |
| MSN PHARMACHEM PRIVATE LIMITED Sangareddy District | IN | CEP 2025-237 - Rev 00 Memantine hydrochloride, Crystalline Form-I, Micronised and Non-micronised | Nov 2025 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Memantine Hydrochloride are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- China · Inactive DMF 37704 · filed Nov 2022
- RANBAXY LABORATORIES LTDInactive DMF 20941 · filed Oct 2007
- TAI HENG INDUSTRY CO LTDInactive DMF 20151 · filed Apr 2007
- India · Inactive DMF 20388 · filed Mar 2007
- ESTEVE QUIMICA SAInactive DMF 19024 · filed Dec 2005
- Spain · Inactive DMF 18436 · filed Jun 2005
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Memantine Hydrochloride is a medication used to treat moderate-to-severe Alzheimer's disease. It works by blocking the action of glutamate in the brain, which is believed to contribute to the symptoms of Alzheimer's.
Chemical identity
- IUPAC name
- 3,5-dimethyladamantan-1-amine;hydrochloride
- Canonical SMILES
- CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl
- InChIKey
- LDDHMLJTFXJGPI-UHFFFAOYSA-N
- Synonyms
- Namenda API, acrescent, akatinol, auxura, balaxur, ebixa, fp-01, marixino, memantine accord, memantine hcl, memantine lek, memantine merz
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- N-methyl-D-aspartate Receptor Antagonist
- Mechanism of action
- NMDA Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Memantine Hydrochloride?
29 organisations hold an active US FDA Type II Drug Master File or a CEP for Memantine Hydrochloride: Alembic Pharmaceuticals Limited (India), Hetero Drugs Limited (India), HIKAL LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), MSN PHARMACHEM PRIVATE LTD (India), TAPI NL BV (Netherlands), Zhejiang Supor Pharmaceuticals Co., Ltd (China) and AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPA (Italy), and 21 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Memantine Hydrochloride Drug Master Files are active?
Alembic Pharmaceuticals Limited (DMF 23108), Hetero Drugs Limited (DMF 24778), HIKAL LTD (DMF 23567), MATRIX PHARMACORP PRIVATE LTD (DMF 20362), MSN PHARMACHEM PRIVATE LTD (DMF 22112), TAPI NL BV (DMF 20868), Zhejiang Supor Pharmaceuticals Co., Ltd (DMF 38425) and AMSA ANONIMA MATERIE SINTETICHE AND AFFINI SPA (DMF 19549) and 19 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Memantine Hydrochloride records mean?
6 organisations have only inactive Type II DMFs for Memantine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Memantine Hydrochloride have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Memantine Hydrochloride on the EDQM register, including HIKAL LIMITED Bengaluru (IN), ZHEJIANG SYNCOTIDE BIO-PHARMACEUTICAL CO., LTD. Shaoxing (CN), TAPI NL B.V. Amsterdam (NL), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN) and KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto (SI) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Memantine Hydrochloride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Memantine Hydrochloride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.